ciprofloxacin has been researched along with Carcinoma, Small Cell in 4 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Carcinoma, Small Cell: An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Timmer-Bonte, JN | 1 |
| de Boo, TM | 1 |
| Smit, HJ | 1 |
| Biesma, B | 1 |
| Wilschut, FA | 1 |
| Cheragwandi, SA | 1 |
| Termeer, A | 1 |
| Hensing, CA | 1 |
| Akkermans, J | 1 |
| Adang, EM | 1 |
| Bootsma, GP | 1 |
| Tjan-Heijnen, VC | 2 |
| Marinkovic, M | 1 |
| Witmer, JP | 1 |
| Bunn, PA | 1 |
| Postmus, PE | 1 |
| Ardizzoni, A | 1 |
1 trial available for ciprofloxacin and Carcinoma, Small Cell
| Article | Year |
|---|---|
Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Antineoplastic Combin | 2005 |
3 other studies available for ciprofloxacin and Carcinoma, Small Cell
| Article | Year |
|---|---|
[Diagnostic image (299). An oncology patient suffering from conjunctivitis].
Topics: Anti-Infective Agents; Antineoplastic Agents; Antineoplastic Protocols; Carcinoma, Small Cell; Cipro | 2006 |
Editorial comments on 'Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: an EORTC double-blind placebo-controlled phase III study'.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Antineoplastic Combined Chemot | 2001 |
Reply to the article "Editorial comments on 'reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: an EORTC double-blind placebo-controlled phase III study'", by P.
Topics: Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cipro | 2002 |